Sirona Biochem (CVE:SBM) Shares Down 16.7% – Here’s What Happened

Sirona Biochem Corp. (CVE:SBM)’s stock price was down 16.7% during mid-day trading on Tuesday . The company traded as low as C$0.05 and last traded at C$0.05. Approximately 113,000 shares traded hands during trading, an increase of 91% from the average daily volume of 59,069 shares. The stock had previously closed at C$0.06.

Sirona Biochem Stock Performance

The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The firm has a market capitalization of C$12.84 million, a PE ratio of -5.00 and a beta of -0.03. The firm’s fifty day moving average price is C$0.06 and its 200 day moving average price is C$0.06.

Sirona Biochem Company Profile

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.